wire

« BACK

Pharmacology



Results 1 - 50 of 266.
1 2 3 4 5 6 Next »


Health - Pharmacology - 15.10.2020
UCL academics named as Future Leaders Fellows
Seven UCL academics have been awarded UKRI Future Leaders fellowships, and will receive government investment to support their research.

Health - Pharmacology - 08.10.2020
Role-playing computer game helps players understand how vaccines work on a global scale
Role-playing computer game helps players understand how vaccines work on a global scale
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.

Health - Pharmacology - 08.10.2020

Health - Pharmacology - 01.10.2020
Opinion: Coronavirus - the three types of vaccine hesitancy authorities need to combat
Honorary Research Associate Annamaria Carusi (UCL Science & Technology Studies) examines the three types of vaccine hesitancy facing authorities' efforts to build public trust in a coronavirus vaccine, including fears over civil liberties, animal welfare and testing.

Health - Pharmacology - 30.09.2020
New trial to treat Covid-19 in care homes using anti-TNF drug begins
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.

Health - Pharmacology - 30.09.2020
Opinion: Coronavirus - how the pharma industry is changing to produce a vaccine on time
Research Fellow Beatrice Melinek and Dr Stephen Morris (both UCL Biochemical Engineering) write how medical developments accelerate during crises, and share hopes for the production of a successful vaccine for Covid-19. To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor - and it needs to happen quickly.

Health - Pharmacology - 27.09.2020
Analysis: A million deaths from coronavirus - seven experts consider key questions
Professor Susan Michie (UCL Psychology & Languages Sciences) and Professor Robert West (UCL Epidemiology & Health) join experts in answering questions about the coronavirus, future pandemics and call for "a long-term vision and commitment to have short-term future success.

Life Sciences - Pharmacology - 21.09.2020
Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks
Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks
Professor Imre Berger University of Bristol Professor Christiane Schaffitzel University of Bristol 3D structure image of SARS CoV-2 Spike protein University of Bristol 21 September 2020 A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the virus from infecting human cells has been discovered by an international team of scientists led by the University of Bristol.

Health - Pharmacology - 16.09.2020
New £4m study to advance our understanding of severe coronavirus infection
The University of Liverpool is leading a major new international project to improve our understanding of severe coronavirus infection in humans, together with collaborators from the University of Oxford, Public Health England, the University of Bristol; A*STAR in Singapore; and King Fahd Medical City in Saudi Arabia.

Health - Pharmacology - 16.09.2020
RECOVERY COVID-19 phase 3 trial to evaluate Regeneron’s REGN-COV2 antibody cocktail
One of the world's largest efforts to find effective COVID-19 treatments will evaluate the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation. Regeneron Pharmaceuticals, Inc. and the University of Oxford today announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world's largest randomised clinical trials of potential COVID-19 treatments, will evaluate Regeneron's investigational anti-viral antibody cocktail, REGN-COV2.

Health - Pharmacology - 11.09.2020
Global consortium launches new study into long-term effects of COVID-19
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow's Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19.

Health - Pharmacology - 07.09.2020
New global COVID-19 long term study launched
Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19. The international, multi-site study is launched by ISARIC to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19. The researchers are inviting hospitals and healthcare sites worldwide to join this new study.

Health - Pharmacology - 03.09.2020

Health - Pharmacology - 28.08.2020
Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus
Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus
The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19.

Health - Pharmacology - 28.08.2020
Welsh scientists join UK effort to understand how the immune system responds during Covid-19
Evidence from the pandemic has shown that the immune system can help protect people from Covid-19, but it can also cause damage in severe disease.

Health - Pharmacology - 28.08.2020
University of Birmingham immunologist to lead major UK study to search for answers on COVID-19
The UK Coronavirus Immunology Consortium (UK-CIC) will receive £6.5 million to bring together leading immunologists from 17 research institutions A major new project, led by a University of B

Health - Pharmacology - 20.08.2020
Analysis: How UCL clinicians invented a new way of treating breast cancer
As a large trial confirms the effectiveness of single-dose radiotherapy in treating breast cancer, Principle Investigator, Professor Jayant Vaidya (UCL Surgery & Interventional Science), describes how he and colleagues developed a new therapy which challenged convention.

Health - Pharmacology - 19.08.2020
Researchers extend recruitment to COVID-19 vaccine trial
Researchers at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), North Bristol NHS Trust (NBT) and the University of Bristol have begun a new round of recruitment to a clinical trial of a vaccine pioneered in the UK which could protect against COVID-19.

Pharmacology - Health - 13.08.2020
South Africa research team to establish ‘hub’ for discovery of new antibiotics
An international research collaboration, which includes the University of Bristol, has received funding to discover and accelerate the development of new antibiotics.

Pharmacology - Health - 12.08.2020
Opinion: Putin’s dangerous vaccine gamble
Prospective students Current students UCL in the media Services for media Tell us your story Professor Francois Balloux (UCL Genetics, Evolution & Environment) highlights the political sentiment

Pharmacology - Health - 11.08.2020
Over 55s needed for vaccine trial in Greater Glasgow and Clyde
People in good health and over the age of 55 years old are being asked to take part in a COVID-19 vaccine trial.

Health - Pharmacology - 11.08.2020
Researchers to study the impact of Covid-19 in lower and middle-income countries
Glasgow researchers to study the impact of Covid-19 in lower and middle-income countries An international team of researchers, led by the University of Glasgow, has received an award to study the imp

Health - Pharmacology - 07.08.2020
UK-India experts’ drive to stop antibiotic waste creating more ’superbugs’
Waste generated by India's drug manufacturing industry could be damaging environmental bacteria and creating ‘superbugs' that are resistant to antibiotics - prompting a UK-India scientific intervention.

Environment - Pharmacology - 06.08.2020
India-UK team tackles Antimicrobial Resistance spread in waterways
British and Indian experts are joining forces to investigate the impact that releasing antibiotics from antibiotic manufacturing into India's waterways has on the spread of potentially fatal drug-resistant infections.

Health - Pharmacology - 03.08.2020
UCL Technology Fund announces first close of £100m Fund 2
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB) (the university's commercialisation company and part of UCL Innovation & Enterprise), announces first close of a £100m target Fund 2.

Health - Pharmacology - 24.07.2020
Covid-19 vaccine trialled in healthy volunteers
A UCL supported trial, which is testing the Covid-19 vaccine candidate developed by Imperial College London, is now recruiting members of the public at UCLH.

Health - Pharmacology - 24.07.2020
UCL supports trialling of Covid-19 vaccine in healthy volunteers
A UCL supported trial, which is testing the Covid-19 vaccine candidate developed by Imperial College London, is now recruiting members of the public at UCLH.

Health - Pharmacology - 16.07.2020
Trial to explore more effective treatments for seriously ill COVID-19 patients
A major trial is underway to explore how artificial intelligence can be used to develop more effective treatments for very ill COVID-19 patients.

Pharmacology - Psychology - 15.07.2020
You can see it in their eyes: Traumatic experiences leave mark on pupils
The pupils of people with post-traumatic stress disorder respond differently to those without the condition when they look at emotional images, a new study has found. The study looked for traces of traumatic events in the eyes of patients with PTSD, which can occur following a distressing event and causes greater sensitivity, or hyperarousal, to everyday events and an inability to switch off and relax.

Health - Pharmacology - 15.07.2020
UofG to play key role in new study into COVID-19 long-term health impacts
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched. The PHOSP-COVID study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Department of Health and Social Care.

Health - Pharmacology - 10.07.2020
Helping track and reduce COVID-19 infections in Northeast Brazil
A combination of thermal drones, artificial intelligence and mathematical modelling is helping scientists track and reduce the spread of COVID-19 in Northeast Brazil: one of a series of innovative coronavirus research initiatives being carried out by UCL and scientists in Brazil.

Health - Pharmacology - 10.07.2020
Cystic fibrosis drug trialled to fight inflammation caused by COVID-19
Patients with COVID-19 will be given the cystic fibrosis drug 'Dornase alfa' to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.

Health - Pharmacology - 09.07.2020

Social Sciences - Pharmacology - 08.07.2020
New guidance launched to help people from Punjabi community with alcohol problems
The authors' recommendations provide a framework for supporting people from other communities with alcohol problems who are not engaging with existing services.

Pharmacology - 03.07.2020
Over the counter anti-inflammatory drugs could be damaging the health of runners
Anti-inflammatory drugs, such as over-the-counter ibuprofen, are commonly used by runners to ease post-exercise aches, pains or injuries, but carry a risk of harm according to a new study into the use of the pain killers by recreational runners in the UK. Non-steroidal anti-inflammatories (NSAIDs) block the production of inflammatory chemicals called prostaglandins, which reduces pain and inflammation, however they also block protective prostaglandins in the stomach and prostaglandins that help maintain kidney function.

Pharmacology - Health - 29.06.2020
New artificial heart valve could transform open-heart surgery
New artificial heart valve could transform open-heart surgery
A new type of artificial heart valve, made of long-lived polymers, could mean that millions of patients with diseased heart valves will no longer require lifelong blood-thinning medication after valve replacement surgery. These impressive results show the PoliValve is a promising alternative for valve replacement surgery Geoff Moggridge The valve, called PoliValve, has been developed by scientists at the Universities of Cambridge and Bristol.

Health - Pharmacology - 29.06.2020
Children at risk from falling UK vaccination rates, warn doctors
Children risk becoming 'unseen victims of the COVID-19 pandemic', with evidence suggesting they may be missing routine vaccinations, warn researchers.

Health - Pharmacology - 23.06.2020
Parliamentarians hear of 'high chance' of coronavirus vaccine
Parliamentarians hear of ’high chance’ of coronavirus vaccine
Two of Imperial's leading coronavirus experts gave evidence to the House of Lords about their research to tackle COVID-19 Professor Robin Shattock, who is developing a vaccine for COVID-19 and Profes

Health - Pharmacology - 23.06.2020
First volunteer receives Imperial COVID-19 vaccine
The first healthy volunteer has now received a candidate coronavirus vaccine developed by researchers. The clinical team, who delivered a small dose of the vaccine to the participant at a West London facility, are closely monitoring the participant and report they are in good health, with no safety concerns.

Health - Pharmacology - 19.06.2020
Missed eye appointments may increase sight loss post-lockdown
The COVID-19 lockdown is threatening the sight of thousands of elderly people across the UK as eye clinics have reported more than a 70% reduction in new referrals and a high rate of missed appointments, finds a new study co-led by UCL.

Health - Pharmacology - 18.06.2020
Tackling COVID-19: Professor Ravi Gupta
"This virus is probably going to be circulating for years - it will take a long time to sort out." In a building that has been largely empty for the past three months, Ravi Gupta has been working non-stop alongside other virus experts.

Health - Pharmacology - 16.06.2020
Liver perfusion could save 7 in 10 rejected donor livers
A major study investigating the effectiveness of liver perfusion as a technique to improve the function of donor livers that would have otherwise been rejected has shown that up to 7 in every 10 could be used after just 4-6 hours of the assessment. The study, ‘ Transplantation of discarded livers following viability testing with normothermic machine perfusion' , published today , could have significant implications for the liver transplant waiting list and the commissioning of local transplant services.

Health - Pharmacology - 15.06.2020
Imperial to begin first human trials of new COVID-19 vaccine
Imperial to begin first human trials of new COVID-19 vaccine
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London.

Health - Pharmacology - 12.06.2020
Understanding the link between Covid-19 and cardiovascular diseases  
Scientists at UCL will lead two 'flagship' studies, announced by the British Heart Foundation (BHF) and the National Institute for Health Research (NIHR), which will investigate the link between Covid-19 and heart disease.
1 2 3 4 5 6 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |